Symic Biomedical's Series B Round

Symic Biomedical raised a round of funding on May 22, 2017.

Symic Bio is developing a new category of therapeutics that offer an exciting biological approach to treating disease. While it is clear that cells play an important role in tissue inflammation and re…

Articles about Symic Biomedical's Series B Round: